Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Nutritional Assessment in Non-tuberculous Mycobacteria Pulmonary Disease: an Exploratory Study
Authors not listed
University of Milano Bicocca · 2022
Abstract
Non-tuberculous mycobacterial (NTM) pulmonary disease (PD) is an emerging condition with heterogeneous manifestations from both the microbiological and the clinical point of view. Diagnostic and therapeutic guidelines are available but there are still unmet patients' and physicians' needs, including the exams to perform in the nutritional evaluation and intervention to improve health-related QoL and to control gastrointestinal side-effects during antimicrobial therapy, particularly in those with low body mass index and history of weight loss.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-18 MST
Cite this
APA
Anonymous. (2022). Nutritional Assessment in Non-tuberculous Mycobacteria Pulmonary Disease: an Exploratory Study. <em>University of Milano Bicocca</em>. https://clinicaltrials.gov/study/NCT05376280
Vancouver
Anonymous. Nutritional Assessment in Non-tuberculous Mycobacteria Pulmonary Disease: an Exploratory Study. University of Milano Bicocca. 2022.
BibTeX
@misc{anon2022Nutrit,
title = {Nutritional Assessment in Non-tuberculous Mycobacteria Pulmonary Disease: an Exploratory Study},
author = {Anonymous},
journal = {University of Milano Bicocca},
year = {2022},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
MacSphere (McMaster University) 2019
Preprint · OA
Investigating the Extracellular Matrix in Pulmonary Fibrosis
Biochemical and biophysical research communications 2026
Citation only
Chiglitazar prevents diabetes-induced skeletal muscle loss by enhancing myogenic differentiation through the MEK/ERK pathway.
Nephrology Dialysis Transplantation 2018
Citation only
FP115KIDNEY BIOPSY IN THE ELDERLY: FRAILTY INDEX IS A GOOD TOOL TO PREDICT CLINICAL OUTCOMES
British Journal of Hospital Medicine 2018
Citation only
The pulmonary rehabilitation regimen: a treatment for frailty and ‘inflammaging’?
Journal of Cachexia Sarcopenia and Muscle 2022
Open access · CC-BY
Associations between frailty trajectories and cardiovascular, renal, and mortality outcomes in chronic kidney disease
Exploration of Medicine 2020
Open access · CC-BY